Home Compare MRNA vs SDF.DE
Stock Comparison · Structural lead, mixed market

Moderna vs K+S Aktiengesellschaft: Which Stock Looks Stronger in 2026?

K+S Aktiengesellschaft holds the cleaner structural position, with the lead spread across valuation and stability. Moderna does not offset that deficit through any equally strong structural edge elsewhere. In the market, Moderna carries the stronger setup — intact trend against K+S Aktiengesellschaft's broken trend. That leaves a split case: the structural lead stays with K+S Aktiengesellschaft, but the market is not currently confirming it.

The comparison is based on similar long-term financial trajectories, not sector labels. Peer scores are normalised within each company's primary universe (MRNA: S&P 500, SDF.DE: HDAX).

Updated 2026-07-05

This is not just a one-metric split: both valuation and stability materially support the lead. The overall score gap is 26 points in favour of K+S Aktiengesellschaft.

Trajectory Similarity
0.69
Moderately similar
Peer-set rank: #1
within Moderna, Inc.'s functional peer set

This pair is matched through long-term financial trajectory similarity within the selected peer universe.

This level of similarity points to a meaningful structural match, though not a tight one.

The clearest structural overlap shows up in investment intensity and revenue stability.

Similarity drivers
investment intensityrevenue stability
What reduces the match
margin consistency
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
MRNA
Moderna, Inc.
35
Peer-Score
Signal qualitylow
Peer basis: S&P 500
vs
SDF.DE
K+S Aktiengesellschaft
61
Peer-Score
Signal qualityMedium
Peer basis: HDAX

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The largest gaps do not all point in the same direction.

Dimension spread: MRNA vs SDF.DE Profitability 17 9 Stability 4 59 Valuation 30 88 Growth 100 100 MRNA SDF.DE
Gap Ranking
#1 Valuation +58
#2 Stability +55
#3 Profitability +8
#4 Growth
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for MRNA and SDF.DE Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer MRNASDF.DE Relative valuation Structural strength

K+S Aktiengesellschaft looks stronger on relative valuation, while the broader price setup remains mixed.

Valuation position uses peer-relative valuation score and Forward P/E where available.

Entry today — historical context

Where MRNA and SDF.DE each sit in their own 5-year price and valuation history.

BASED ON 5-YEAR HISTORY MRNA Neutral · below norm 0th 50th 100th 6 pct gap SDF.DE Neutral · near norm 0th 50th 100th 39th 45th
MRNA (39th percentile) and SDF.DE (45th percentile) both sit in the lower-middle of their own 5-year ranges. The historical entry context is broadly similar for both. This reflects entry timing, not which company is structurally stronger.

Describes historical entry positioning only. Descriptive — not investment advice.

Relative Position vs Comparable Companies
Valuation
K+S Aktiengesellschaft ranks near the top of the group on valuation; Moderna, Inc. sits in the weaker half.
Stability
On stability, K+S Aktiengesellschaft is positioned higher in the group, while Moderna, Inc. is closer to the middle.
Valuation — Dominant Gap
MRNA
30
SDF.DE
88
Gap+58in favour of SDF.DE

The main spread comes from a meaningfully cheaper peer-relative valuation.

What keeps the gap from being one-sided

On the market side, Moderna carries the stronger trend while K+S Aktiengesellschaft's trend has broken — the market setup does not confirm the structural advantage.

What this means for the comparison

The lead is built on both valuation and stability, making it broader than a single-dimension result.

Explore full peer positioning in AssetNext

Break down the MRNA vs SDF.DE comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar valuation-and-stability comparisons

Explore how MRNA and SDF.DE each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.